SCHEMBL15435517

SCHEMBL15435517

Cc1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2Cl)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.62
ALDH1A1 P00352 2/20 0.62
MEN1 O00255 5/20 0.62
KMT2A Q03164 5/20 0.62
RAB9A P51151 3/20 0.61
NPC1 O15118 2/20 0.61
CHRNA7 P36544 1/20 0.61
LMNA P02545 2/20 0.60
MAPT P10636 3/20 0.58
TP53 P04637 1/20 0.58
GAA P10253 1/20 0.58
CYP2D6 P10635 2/20 0.58
CYP2C19 P33261 2/20 0.58
CYP3A4 P08684 1/20 0.57
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
HTT P42858 2/20 0.56
KDR P35968 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20472469 0.87 CHRNA7 (0.76) CYP1A2ALDH1A1MEN1KMT2ACHRNA7
SCHEMBL29776952 0.87 CHRNA7 (0.76) CYP1A2ALDH1A1MEN1KMT2ACHRNA7
SCHEMBL13613542 0.86 KDR (0.69) CYP1A2ALDH1A1MEN1KMT2ARAB9A
SCHEMBL3673117 0.86 CHRNA7 (0.60) CYP1A2ALDH1A1MEN1KMT2ACHRNA7
SCHEMBL13541769 0.85 CA12 (0.69) MEN1KMT2ARAB9ANPC1LMNA
SCHEMBL11007737 0.84 MEN1 (0.61) CYP1A2ALDH1A1MEN1KMT2ARAB9A
SCHEMBL3681047 0.83 CHRNA7 (0.67) CYP1A2ALDH1A1MEN1KMT2ACHRNA7
SCHEMBL11191891 0.83 KDR (0.61) CYP1A2ALDH1A1MEN1KMT2ACHRNA7
SCHEMBL16946637 0.82 EPHX2 (0.81) MEN1KMT2ARAB9ANPC1LMNA
SCHEMBL4247303 0.82 MEN1 (0.64) ALDH1A1MEN1KMT2ARAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957077-B1 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER HEALTHCARE LLC (US) 2014-01-22 EP disclosed